Clinical Research
IQVIA MedTech delivers lifecycle-aligned clinical research solutions to help generate the right evidence from early feasibility through post-market studies.
Insight Brief
Navigating the IVD Market: Proven Strategies for Commercial Success
Expert IVD insights and case studies illustrate how proactive planning and an integrated approach to evidence generation can expedite timelines and lower costs.
Jul 28, 2026
Bringing an in vitro diagnostic (IVD) to market requires strong clinical, regulatory, and reimbursement strategy. Misalignment in any area can delay market access, limit adoption, or diminish long term value. As the IVD industry becomes more diversified, competitive, and global, proactive coordination across disciplines is a prerequisite for competitive market entry. By aligning regulatory strategy, clinical evidence generation, and reimbursement planning early in the development process, IVD developers can build both the data and strategies for global commercial success.
Authored by David Kowalski, Michelle Bulliard, Eric Kong and Nicole Fitzpatrick, this insight brief includes expert IVD insights and case studies that illustrate how proactive planning and an integrated approach to evidence generation can expedite timelines and lower costs.
Related solutions
Regulatory
From first submission to global expansion, we help MedTech innovators anticipate regulatory requirements, strengthen submissions, and manage risk across the product lifecycle.
Reimbursement
IQVIA MedTech helps innovators plan for coverage early, aligning reimbursement strategy with regulatory and clinical insight to support a clearer path from approval to adoption.
MedTech Therapeutic Area
Our team works alongside your team, offering integrated medical device therapeutic expertise, technology, and processes to support a clearer understanding of the science, the patient, and the path forward.